Showing results 1 to 4 of 4
A novel imidazopyridine analogue as a phosphatidylinositol 3-kinase inhibitor against human breast cancer Lee, Hyunseung; Li, Guang-Yong; Jeong, Yujeong; Jung, Kyung Hee; Lee, Ju-Hee; Ham, Kyungrok; Hong, Sungwoo; et al, CANCER LETTERS, v.318, no.1, pp.68 - 75, 2012-05 |
A novel imidazopyridine derivative, HS-106, induces apoptosis of breast cancer cells and represses angiogenesis by targeting the PI3K/mTOR pathway Li, Guang-Yong; Jung, Kyung Hee; Lee, Hyunseung; Son, Mi Kwon; Seo, JuHyeon; Hong, Sang-Won; Jeong, Yujeong; et al, CANCER LETTERS, v.329, no.1, pp.59 - 67, 2013-02 |
Biphasic regulation of osteoblast development via the ERK MAPK-mTOR pathway Kim, Jung-Min; Yang, Yeon-Suk; Hong, Jaehyoung; Chaugule, Sachin; Chun, Hyonho; van Der Meulen, Marjolein C. H.; Xu, Ren; et al, ELIFE, v.11, 2022-08 |
Virtual screening and biochemical evaluation to identify new inhibitors of mammalian target of rapamycin (mTOR) Park, Hwangseo; Choe, Hyeonjeong; Hong, Sungwoo, BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.24, no.3, pp.835 - 838, 2014-02 |
Discover